Tag: Drug Development
-
Innovent Highlights Broad Biomedicine Pipeline at 2025 ACR Annual Meeting
Innovent Showcases Broad Biomedicine Pipeline at 2025 ACR Annual Meeting Innovent Biologics, a leading biopharmaceutical company focused on developing, manufacturing, and commercializing high-quality medicines, today highlighted multiple research results from its general biomedicine pipeline at the 2025 American College of Rheumatology (ACR) Annual Meeting. The event, held in San Francisco with contributions from Innovent’s teams…
-
Why India Is a Leading Driver in the Global Killer Superbug Crisis
Introduction: A Global AMR Alarm Becomes Personal for India Antimicrobial resistance (AMR) is not a distant threat. It is shaping real-world outcomes where common infections once easily treated are turning deadly. Recent findings from the World Health Organization (WHO) and landmark studies reported by The Lancet reveal that India is among the countries bearing a…
-
Global Surge in Antibiotic-Resistant Infections in Hospitals Warns of Rising Mortality
Overview: A Growing Threat in Hospitals Worldwide Hospitals across the globe are facing an alarming increase in infections that resist standard antibiotic treatments. The World Health Organization (WHO) Global Antibiotic Resistance Surveillance report draws on data from more than 23 million bacterial infections across 104 countries, revealing that one in six laboratory-confirmed infections in 2023…
-
COMBINEDBrain and MUSC Launch Pediatric CNS Biorepository
Overview of a pivotal collaboration COMBINEDBrain, a leader in translational neuroscience research, and the Medical University of South Carolina (MUSC), a top academic health center, have announced a strategic partnership to establish a cutting-edge biorepository focused on pediatric central nervous system (CNS) tissue and biofluids. Guided by MUSC’s Dr. Ramin Eskandari and COMBINEDBrain’s Dr. Anna…
-
CombinedBrain and MUSC Launch Pediatric CNS Biorepository
A landmark collaboration in pediatric neurobiobank development COMBINEDBrain and the Medical University of South Carolina (MUSC) announced a strategic partnership to establish a cutting-edge biorepository focused on pediatric central nervous system (CNS) tissue and biofluids. Led by MUSC’s Dr. Ramin Eskandari and COMBINEDBrain’s Dr. Anna Pfalzer, the initiative aims to accelerate translational neuroscience, helping drug…
-
Pediatric CNS Biorepository Launch: COMBINEDBrain and MUSC Unite
Overview: A strategic collaboration to accelerate neuroscience research COMBINEDBrain and the Medical University of South Carolina (MUSC) have joined forces to establish a cutting-edge biorepository for pediatric central nervous system (CNS) tissue and biofluids. Led by MUSC’s Dr. Ramin Eskandari and COMBINEDBrain’s Dr. Anna Pfalzer, the alliance aims to accelerate the development of therapies for…
-
Disabling a Cellular ‘Entry Code’ Could Stop Deadly Rotavirus Infection
New Target in the War Against Rotavirus Rotavirus remains a leading cause of severe dehydrating diarrhea in infants and young children, claiming more than 128,500 lives globally each year despite broad vaccination efforts. In the United States, a worrying trend toward waning vaccine uptake has coincided with rising rotavirus cases in recent years. A team…
-
New Hope from Stonefish Venom: Potential Immunosuppressive Drugs
Stonefish venom study sparks hope for new immunosuppressive drugs Researchers from James Cook University (JCU) have uncovered powerful immunosuppressive properties in the venoms of two stonefish species, marking a potential breakthrough in the search for new anti-inflammatory medicines. The work, conducted at JCU’s Australian Institute of Tropical Health and Medicine, suggests that components of these…
-
Stonefish Venom Could Fuel New Immune-Targeting Drugs
Groundbreaking Findings from a Tropical Health Institute Researchers in Australia have unveiled compelling evidence that venoms from two stonefish species possess powerful immunosuppressive properties. The study, led by Dr Silvia Luiza Saggiomo and conducted within the Australian Institute of Tropical Health and Medicine, suggests that the venom can dampen inflammatory processes at the cellular level.…
-
Oncology, Immunology, and Diabetes: China’s Spectacular Breakthrough in Therapeutic Innovation
China’s Rising Role in Therapeutic Innovation In recent years, China has transformed from a manufacturing powerhouse into a global hub of therapeutic innovation. Across oncology, immunology, and diabetes care, researchers and biotechs are delivering new approaches that challenge conventional treatment paradigms. The shift is driven by a mix of heavy investment, ambitious talent pipelines, and…